- Home
- ERAS vs BGR Comparison
ERAS vs BGR Comparison
Compare ERAS & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- BGR
- Stock Information
- Founded
- ERAS 2018
- BGR 2004
- Country
- ERAS United States
- BGR United States
- Employees
- ERAS N/A
- BGR N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- BGR Trusts Except Educational Religious and Charitable
- Sector
- ERAS Health Care
- BGR Finance
- Exchange
- ERAS Nasdaq
- BGR Nasdaq
- Market Cap
- ERAS 396.6M
- BGR 338.6M
- IPO Year
- ERAS 2021
- BGR N/A
- Fundamental
- Price
- ERAS $1.39
- BGR $12.50
- Analyst Decision
- ERAS Strong Buy
- BGR
- Analyst Count
- ERAS 6
- BGR 0
- Target Price
- ERAS $4.83
- BGR N/A
- AVG Volume (30 Days)
- ERAS 1.4M
- BGR 73.3K
- Earning Date
- ERAS 05-20-2025
- BGR 01-01-0001
- Dividend Yield
- ERAS N/A
- BGR 6.02%
- EPS Growth
- ERAS N/A
- BGR N/A
- EPS
- ERAS N/A
- BGR 0.69
- Revenue
- ERAS N/A
- BGR N/A
- Revenue This Year
- ERAS N/A
- BGR N/A
- Revenue Next Year
- ERAS N/A
- BGR N/A
- P/E Ratio
- ERAS N/A
- BGR $18.97
- Revenue Growth
- ERAS N/A
- BGR N/A
- 52 Week Low
- ERAS $1.01
- BGR $11.38
- 52 Week High
- ERAS $3.45
- BGR $13.37
- Technical
- Relative Strength Index (RSI)
- ERAS 51.46
- BGR 50.90
- Support Level
- ERAS $1.37
- BGR $12.29
- Resistance Level
- ERAS $1.61
- BGR $12.64
- Average True Range (ATR)
- ERAS 0.14
- BGR 0.20
- MACD
- ERAS 0.00
- BGR 0.06
- Stochastic Oscillator
- ERAS 45.68
- BGR 74.55
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.